Advanced extrahepatic cholangiocarcinoma and gallbladder cancer: Post-hoc analysis of the ABC-01, -02 and -03 clinical trials.

In relation to PFS ( Supplementary Material S4 and Supplementary Material S5 ), GBC had the worst outcomes (dCCA median PFS 6.63 months; 95% CI: 4.40–8.44; pCCA median PFS 7.55 months; 95% CI: 4.93–8.37; iCCA median PFS 7.55 months; 95% CI: 5.35–8.47; GBC median PFS 6.30 months; 95% CI: 5.71–7.36; Supplementary Material S5 ), even though differences did not reach statistical significance (HR 1.25; 95% CI: 0.91–1.73; p = 0.170).

also in 111,027 other papers